Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
Arthritis and Rheumatism|June 10, 2004
Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trialNorihiro Nishimoto, Kazuyuki Yoshizaki, Nobuyuki Miyasaka, et al.
Modern Rheumatology|November 21, 2013
Immune response to influenza vaccine and pneumococcal polysaccharide vaccine under IL-6 signal inhibition therapy with tocilizumabTomomi Tsuru, Kimio Terao, Miho Murakami, et al.
Arthritis Research & Therapy|January 6, 2009
Interactions among type I and type II interferon, tumor necrosis factor, and beta-estradiol in the regulation of immune response-related gene expressions in systemic lupus erythematosusHooi-Ming Lee, Toru Mima, Hidehiko Sugino, et al.
Langenbeck'S Archives of Surgery|August 19, 2007
Uneventful splenectomy and cholecystectomy in a patient treated with anti-interleukin-6 receptor antibody therapyMorihiko Ishizaki, Tetsuro Sasada, Akane Kunitomi, et al.
Rheumatology International|September 13, 2011
Serum level of oxidative stress marker is dramatically low in patients with rheumatoid arthritis treated with tocilizumabMakoto Hirao, Naomi Yamasaki, Hiroki Oze, et al.
Modern Rheumatology|October 21, 2025
Effectiveness and safety of tocilizumab, an anti-interleukin-6 receptor antibody, in 342 Japanese patients with multicentric Castleman disease: a 3-year, prospective, observational studyNorihiro Nishimoto, Miho Murakami, Takeshi Johkoh, et al.
Arthritis and Rheumatism|March 8, 2005
Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritisShumpei Yokota, Takako Miyamae, Tomoyuki Imagawa, et al.
American Journal of Primatology|July 20, 2011
Increased positive selection pressure within the complementarity determining regions of the T-cell receptor β gene in New World monkeysTakaji Matsutani, Yoshiki Fujii, Kazutaka Kitaura, et al.
Modern Rheumatology|June 25, 2010
Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI studyJun Hashimoto, Patrick Garnero, Désirée van der Heijde, et al.
The Journal of Rheumatology|September 3, 2016
Differences in Predictive Factors for Sustained Clinical Remission with Abatacept Between Younger and Elderly Patients with Biologic-naive Rheumatoid Arthritis: Results from the ABROAD StudyMasahiro Sekiguchi, Takao Fujii, Kiyoshi Matsui, et al.
Pageof 12